Clinical Infectious Diseases最新文献

筛选
英文 中文
Reply to Keyon. 使用强力氨酚聚氧乙烯醚产生抗菌药耐药性的风险是真实存在的,在充分知情的情况下实施该疗法的必要性也是真实存在的。
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae152
Aniruddha Hazra, Connie Celum, Anne F Luetkemeyer, Jean-Michel Molina, Jeffrey D Klausner
{"title":"Reply to Keyon.","authors":"Aniruddha Hazra, Connie Celum, Anne F Luetkemeyer, Jean-Michel Molina, Jeffrey D Klausner","doi":"10.1093/cid/ciae152","DOIUrl":"10.1093/cid/ciae152","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"229-230"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140157741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological Issues in a Retrospective Study on Short-Course Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections in China. 中国铜绿假单胞菌血流感染短程抗生素治疗回顾性研究中的方法学问题。
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae146
Nobumasa Okumura, Gen Yamada, Kei Yamamoto, Shinya Tsuzuki
{"title":"Methodological Issues in a Retrospective Study on Short-Course Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections in China.","authors":"Nobumasa Okumura, Gen Yamada, Kei Yamamoto, Shinya Tsuzuki","doi":"10.1093/cid/ciae146","DOIUrl":"10.1093/cid/ciae146","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"232-233"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140157740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon. 更正:喀麦隆Stratall ANRS 12110/ESTHER试验中基于病毒学、免疫学、临床和/或依从性标准的HIV耐药性预测。
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciaf001
{"title":"Correction to: Prediction of HIV Drug Resistance Based on Virologic, Immunologic, Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in Cameroon.","authors":"","doi":"10.1093/cid/ciaf001","DOIUrl":"10.1093/cid/ciaf001","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"241"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Acting CAB Plus RPV: It's Not About Weight, It's About the Weight of the Evidence.
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciaf024
Jesús Troya, María Luisa Montes, Juan Emilio Losa, Luis Buzón-Martín
{"title":"Long-Acting CAB Plus RPV: It's Not About Weight, It's About the Weight of the Evidence.","authors":"Jesús Troya, María Luisa Montes, Juan Emilio Losa, Luis Buzón-Martín","doi":"10.1093/cid/ciaf024","DOIUrl":"https://doi.org/10.1093/cid/ciaf024","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection.
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciaf032
{"title":"Correction to: A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection.","authors":"","doi":"10.1093/cid/ciaf032","DOIUrl":"https://doi.org/10.1093/cid/ciaf032","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":"80 1","pages":"242-243"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143254979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study Design and Methodology of Antibiotic Duration in Hematological Patients With Pseudomonas aeruginosa Bloodstream Infection. 铜绿假单胞菌血流感染血液病患者抗生素疗程的研究设计和方法。
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae148
Xiaomeng Feng, Chenjing Qian, Yuping Fan, Jia Li, Jieru Wang, Qingsong Lin, Erlie Jiang, Yingchang Mi, Lugui Qiu, Zhijian Xiao, Jianxiang Wang, Mei Hong, Sizhou Feng
{"title":"Study Design and Methodology of Antibiotic Duration in Hematological Patients With Pseudomonas aeruginosa Bloodstream Infection.","authors":"Xiaomeng Feng, Chenjing Qian, Yuping Fan, Jia Li, Jieru Wang, Qingsong Lin, Erlie Jiang, Yingchang Mi, Lugui Qiu, Zhijian Xiao, Jianxiang Wang, Mei Hong, Sizhou Feng","doi":"10.1093/cid/ciae148","DOIUrl":"10.1093/cid/ciae148","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"233-234"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Start Swinging. 开始摇摆
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae271
Wendy Stead
{"title":"Start Swinging.","authors":"Wendy Stead","doi":"10.1093/cid/ciae271","DOIUrl":"10.1093/cid/ciae271","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"4-6"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conversion or Reversion of Interferon γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-analysis. 结核分枝杆菌感染干扰素γ释放测定的转换或逆转:系统综述和荟萃分析。
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae357
Mao-Shui Wang, Jarrod Li-Hunnam, Ya-Li Chen, Beth Gilmour, Kefyalew Addis Alene, Yan-An Zhang, Mark P Nicol
{"title":"Conversion or Reversion of Interferon γ Release Assays for Mycobacterium tuberculosis Infection: A Systematic Review and Meta-analysis.","authors":"Mao-Shui Wang, Jarrod Li-Hunnam, Ya-Li Chen, Beth Gilmour, Kefyalew Addis Alene, Yan-An Zhang, Mark P Nicol","doi":"10.1093/cid/ciae357","DOIUrl":"10.1093/cid/ciae357","url":null,"abstract":"<p><strong>Background: </strong>Interferon γ release assays (IGRAs) are widely used for diagnosis of latent tuberculosis infection. However, with repeated testing, IGRA transformation (conversion or reversion) may be detected and is challenging to interpret. We reviewed the frequency of and risk factors for IGRA transformation.</p><p><strong>Methods: </strong>We screened public databases for studies of human participants that reported the frequency of IGRA transformation. We extracted study and participant characteristics, details of IGRA testing and results. We calculated the pooled frequency of IGRA transformation (and transient transformation) and examined associated risk factors.</p><p><strong>Results: </strong>The pooled frequency of IGRA conversion or reversion from 244 studies was estimated at 7.3% (95% confidence interval [CI], 6.1%-8.5%) or 22.8% (20.1%-25.7%), respectively. Transient conversion or reversion were estimated at 46.0% (95% CI, 35.7%-56.4%) or 19.6% (9.2%-31.7%) of conversion or reversion events respectively. Indeterminate results seldom reverted to positive (1.2% [95% CI, .1%-3.5%]). IGRA results in the borderline-positive or borderline-negative range were associated with increased risk of conversion or reversion (pooled odds ratio [OR] for conversion, 4.15 [95% CI, 3.00-5.30]; pooled OR for reversion, 4.06 [3.07-5.06]). BCG vaccination was associated with decreased risk of conversion (OR, 0.70 [95% CI, .56-.84]), cigarette smoking with decreased risk of reversion (0.44 [.06-.82]), and female sex with decreased risk of either conversion or reversion (OR for conversion, 0.66 [.58-.75]; OR for reversion, 0.46 [.31-.61]).</p><p><strong>Conclusions: </strong>IGRA conversion is less common than reversion, and frequently transient. Research is needed to determine whether individuals with reversion would benefit from tuberculosis-preventive treatment. Retesting of people with indeterminate results is probably not indicated, because indeterminate results seldom revert to positive.</p>","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"168-179"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an Electronic Clinical Surveillance Measure for Unnecessary Rapid Antibiotic Administration in Suspected Sepsis. 针对疑似败血症患者不必要的快速抗生素用药制定电子临床监控措施。
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae445
Stephanie Parks Taylor, Jessica A Palakshappa, Shih-Hsiung Chou, Kevin Gibbs, Jessie King, Nikhil Patel, Marc Kowalkowski
{"title":"Development of an Electronic Clinical Surveillance Measure for Unnecessary Rapid Antibiotic Administration in Suspected Sepsis.","authors":"Stephanie Parks Taylor, Jessica A Palakshappa, Shih-Hsiung Chou, Kevin Gibbs, Jessie King, Nikhil Patel, Marc Kowalkowski","doi":"10.1093/cid/ciae445","DOIUrl":"10.1093/cid/ciae445","url":null,"abstract":"<p><strong>Background: </strong>Substantial efforts focus on monitoring and reducing delays in antibiotic treatment for sepsis, but little has been done to characterize the balancing measure of sepsis overtreatment. We aimed to establish preliminary validity and usefulness of electronic health record (EHR) data-derived criteria for sepsis overtreatment surveillance (SEP-OS).</p><p><strong>Methods: </strong>We evaluated adults with potential sepsis (≥2 Systemic Inflammatory Response Syndrome criteria within 6 hours of arrival) presenting to the emergency department of 12 hospitals, excluding patients with shock. We defined SEP-OS as the proportion of patients receiving rapid IV antibiotics (≤3 hours) who did not ultimately meet the Centers for Disease Control Adult Sepsis Event \"true sepsis\" definition. We evaluated the frequency and characteristics of patients meeting overtreatment criteria and outcomes associated with sepsis overtreatment.</p><p><strong>Results: </strong>Of 113 764 eligible patients, the prevalence of sepsis overtreatment was 22.5%. The measure met prespecified criteria for reliability, content, construct, and criterion validity. Patients classified by the SEP-OS overtreatment criteria had higher median antibiotic days (4 days [IQR, 2-5] vs 1 day [1-2]; P < .01), longer median length of stay (4 days [2-6] vs 3 days [2-5]; P < .01), higher hospital mortality (2.4% vs 2.1%; P = .01), and higher frequency of Clostridioides difficile infection within 6 months of hospital discharge (P < .01) compared with \"true negative\" cases.</p><p><strong>Conclusions: </strong>We developed a novel, valid EHR metric for clinical surveillance of sepsis overtreatment. Applying this metric to a large cohort of potential sepsis patients revealed a high rate of overtreatment and provides a useful tool to inform sepsis quality-improvement targets.</p>","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"14-23"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Fosfomycin-Containing Regimens in Reducing Mortality From Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales. 含磷霉素的治疗方案在降低产金属β-乳酰胺酶肠杆菌感染死亡率中的作用
IF 8.2 1区 医学
Clinical Infectious Diseases Pub Date : 2025-02-05 DOI: 10.1093/cid/ciae196
Stelios F Assimakopoulos, Markos Marangos
{"title":"The Role of Fosfomycin-Containing Regimens in Reducing Mortality From Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales.","authors":"Stelios F Assimakopoulos, Markos Marangos","doi":"10.1093/cid/ciae196","DOIUrl":"10.1093/cid/ciae196","url":null,"abstract":"","PeriodicalId":10463,"journal":{"name":"Clinical Infectious Diseases","volume":" ","pages":"236-237"},"PeriodicalIF":8.2,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信